Prognostic Significance of Molecular Markers and Targeted Regimens in the Management of Acute Myeloid Leukemia.

Prognostic Significance of Molecular Markers and Targeted Regimens in the Management of Acute Myeloid Leukemia. J Natl Compr Canc Netw. 2018 May;16(5S):656-659 Authors: Tallman M Abstract The diagnosis, staging, and treatment of acute myeloid leukemia (AML) has evolved based on identification of important genetic alterations and drugs to target those genes. Cytogenetic abnormalities play a major role in managing AML. Achieving minimal residual disease is an increasingly important milestone. Four new targeted therapies are now available for the treatment of AML. PMID: 29784749 [PubMed - in process]
Source: Journal of the National Comprehensive Cancer Network : JNCCN - Category: Cancer & Oncology Tags: J Natl Compr Canc Netw Source Type: research